
ACS Expands Colon Cancer Screening With Blood and At-Home Stool Tests
The American Cancer Society updated its colon cancer screening recommendations to include three newer options: two enhanced at-home stool tests (Cologuard Plus and ColoSense) that look for tumor DNA/RNA in stool, and a blood test (Shield) detecting cancer DNA in blood. The goal is to boost screening rates among adults 45–75 by offering more convenient options; stool tests are recommended every three years, the blood test at routine medical visits, and follow-up colonoscopy is still required if any test is positive. Colonoscopy remains the most effective method for detecting polyps and preventing cancer, but these tests provide additional access points and can reduce delays in screening. Insurance coverage varies by plan.



